HMLA Himalaya Technologies Inc (PK)

Item 8.01 Other Events.

On May 24, 2023, Himalaya Technologies, Inc. notified its creditors, auditors, financial advisors and Transfer Agent that the Company does not have funding in place to continue SEC reporting and therefore expects to be delisted to the OTC Expert Market on or around June 16, 2023. Our inability to fund our operations is due to FINRA’s inexplicable refusal to approve shareholder actions for a name change, share increases and creation of new classes of stock, despite management’s provision to FINRA of hundreds of pages of SEC and state filings, legal documents, resolutions, affidavits, explanations, conference call transcripts, and other exhibits.

The compendium of information provided to FINRA over thirteen (13) months in hundreds of emails includes numerous SEC filings of Form 10-12G and Forms 10-12G/A-1-2-3-4 qualified by the SEC on April 6, 2022, a Form 10-K, numerous Forms 10-Q, a Form 1A, Forms 1A/A-1-2-3-4-5-6-7-8, a Form 1A/A-W withdrawal after our Tier 2 Reg A+ offering was previously qualified by the SEC, and multiple Forms 8-K for material information disclosure. In total, these SEC filings along with the provision of all Secretary of State filings since we were incorporated nearly 20 years ago on or around July 8, 2003 in Nevada, in management’s opinion, overwhelmingly support information needed by any reasonable body, agency, Court of Law, or man or woman of any jury, or council to consider and approve our shareholder action filed on June 28, 2021 and approved and stamped by the Secretary of State of Nevada on June 30, 2021.

Our shareholder action included approval of a name change to “Himalaya Technologies, Inc.” from “Homeland Resources Ltd.”, an increase in our authorized common shares to one billion from 100,000,000, an increase in authorized Series A Preferred shares to 130,000,000 from 10,000,000, the creations of a new class of Series B preferred shares and a new class of Series C preferred shares and supporting conversion and voting terms for the Preferred A-B-C classes. We had certain shareholder action filing deficiencies noted by FINRA which we have cured; however, FINRA is challenging our management team’s and prior management’s authority to act as Officers, requesting immaterial resolutions and explanations that our state and federal filings and management affidavits under penalty of felony perjury overwhelmingly address, in our view.

FINRA inexplicably will not recognize the rules of business law in the State of Nevada where we are incorporated, the filings and implied consent of our actions by the SEC whom it reports to, and even the 14^th Amendment of the Constitution of the United States allowing citizens to obtain lawful employment and achieve prosperity free from government interference.

Against this backdrop, we are preparing to delist our common stock to the OTC Expert Market by unwinding all corporate actions taken since June 2021. Meanwhile, we are interviewing law firms to pursue legal action against FINRA for the irreparable damage it has caused our shareholders, creditors, former business partners, acquisitions, minority investments, and affiliates. There are no assurances we will be successful in continuing our business in any fashion, or that we will successfully resolve any future potential legal action against FINRA or other related government agencies responsible for reviewing OTC Corporate Actions and FINRA itself.